Articles related to PHARMACY OPERATIONS & MGMT

Among the 2023 ASHP Pharmacy Forecast panelists, 73% predicted that health systems will be required to validate the safety and effectiveness of AI tools, while only 37% reported that they were prepared to perform the validation.

Multiple system failures – nurse transcription error creating lethal dose, pharmacist failure to question extraordinary opioid amount, and institutional non-disclosure to grieving family – created perfect storm for maximum legal liability.

The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.

Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.

This case exemplifies the dire consequences of unethical practices in the health care and pharmaceutical industries, emphasizing the need for physicians to remain vigilant and uphold the highest ethical standards in patient care and medication prescribing.

The ASHP’s newly revised guidelines offer actionable steps for community pharmacies to combat controlled substance diversion, addressing both patient safety and regulatory compliance.